Why Latin America

Outsourcing Clinical Trials

CRO based in Latin America

The Potential
of LATAM

Historically, most clinical research has been concentrated in developed nations. This trend is obvious from the geographical distribution of clinical research publications; most of the publications and the research itself come from North America and western Europe. 

Nevertheless, the presence of clinical research in Latin America growing steadily in the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.

01

Cost Effectiveness

There are huge financial gains associated with conducting clinical research in Latin America, with up to 50% lower costs when compared to the USA. This is in part because of the materials and actual cost of location for LATAM research centers are less expensive and does not compromise standard-of-care or data validity.

02

Patient Recruitment

With a population of 600M+, LATAM is one of the less exploited regions for patient recruitment when compared with saturated major centers in the USA and Europe. The lack of clinical trials and the strong bond between patients and physicians, make Latin America fertile ground for patient recruitment and retention.

03

Regulatory Agencies

During the last decade most of Latin American countries have opened agencies and adopted new regulations that adhere to the FDA’s international standards. That is why it is crucial to have a local CRO with the expertise to navigate this changing landscape, and locally-based teams with staff who speak the language, which can save a lot of time during the study start-up phase.

Clinical research in Latin America

CRO based in Latin America

CRO based in Latin America

The Cohortias' Difference

cro in mexico

Our Infrastructure in Latin America

Cohortias has built a broad network of sites, physicians, investigators and regulatory experts across the Latin American region. This peer-to-peer model allows us to expedite our clinical trial services from the start-up phases all the way to the study termination. 

Our experience in the region enables us to understand and comply with local regulations, customs, and language differences and to efficiently work with the culture and the medical practices in each country of the region– ensuring superior trial compliance and expeditious patient enrolment.

It also enables us to provide sound advice to our clients on how to prevent difficulties and delays in the implementation and development of the trials.

Full Service CRO

We have the capability and expertise to conduct clinical trials and development projects on both a local, cross-region and global basis and provide the full range CRO services.

Revolutionary Pricing Model

Innovative pricing depending on regulatory approval first, and then on patient recruitment. This offers less risks to our clients.

Latin America = Market Potential

A substantial market for later sale of approved drugs, with registration accelerated by participation in multi-regional clinical trials. We welcome the opportunity to discuss your unique clinical research requirements.
Regulatory Approval Rate
100%
Employee Retention
97%
Client Satisfaction
98%

We Will Help You Every Step Of The Way

Let us guide you through the Clinical Research Landscape of Latin America

CRO based in Latin America

Why Latin America?

Several factors contribute to Latin America being a region of choice to conduct your clinical trials:

Patient Access

Over 600 million inhabitants and 80% urban population. Large metropolitan areas provide patient concentrations for stronger enrollment.

Compliance & Retention

Strong patient-doctor relationship built upon the health infrastructure of each country, this is why drop-out rates in the region are one-third to those of US and EU.

Lack of Language Barrier

Only 2 languages - Spanish and Portuguese. With many english bilingual (English is predominant in the region).

disease prevalence

Cardiovascular, arthritis, cancer, and infectious diseases are as prevalent as in the United States.
Play Video
Transforming Lives Through Clinical Research

Let us help You Navigate LATAM

Contact us for a free consultation

Why Latin America

Cohortias International
  • Latin America (LATAM) is a region known for its diverse patient population, which makes it an attractive destination for clinical research. With a population that encompasses various ethnicities, age groups, and socioeconomic backgrounds, LATAM offers a rich pool of potential study participants.
  • Conducting clinical trials in LATAM presents unique advantages, including access to treatment-naive patients, which can provide valuable insights into the safety and efficacy of investigational drugs. Additionally, the region’s favorable regulatory environment and streamlined approval processes make it conducive to efficient study conduct.
  • With Cohortias, you gain access to our extensive network of research sites across LATAM, ensuring efficient and reliable study conduct. Our team of experienced professionals understands the nuances of conducting trials in the region and can navigate regulatory requirements with ease. Whether you’re seeking to expand your study into LATAM or looking for a partner to oversee the entire trial process, Cohortias has the expertise and resources to support your needs.
  • Our CRO partnering model is designed to foster collaborative relationships with sponsors, ensuring seamless communication and mutual success. We believe in working closely with our clients to understand their unique goals and challenges, allowing us to tailor our services to meet their specific needs.
  • At Cohortias, we view our clients as partners, and we strive to build long-term relationships based on trust, transparency, and shared objectives. Our team is committed to delivering high-quality services and providing proactive support throughout every stage of the clinical trial process.
  • By partnering with Cohortias, you benefit from our expertise in clinical trial management, regulatory compliance, and site selection. Whether you require assistance with study design, protocol development, site monitoring, or data management, we have the knowledge and experience to guide you through the complexities of the drug development process.
  • Cohortias specializes in high-enrollment rescue studies, helping sponsors overcome recruitment challenges and meet study timelines. We understand the critical importance of patient enrollment in the success of a clinical trial and employ innovative strategies to accelerate recruitment.
  • Our experienced team leverages a variety of recruitment tactics, including targeted advertising, patient advocacy groups, and physician referrals, to identify and enroll eligible participants. Additionally, our extensive network of research sites allows us to quickly mobilize resources and expand patient access to investigational treatments.
  • With Cohortias as your partner, you can expect rapid enrollment, efficient study execution, and timely data delivery. We are committed to helping you achieve your recruitment goals and ensuring the success of your clinical trial.
  • Conducting clinical trials in LATAM offers numerous benefits, including diverse patient populations, streamlined regulatory processes, and cost-effective trial conduct. The region’s multicultural demographics and varying disease prevalence rates provide researchers with access to a broad spectrum of patients, facilitating robust data collection and analysis.
  • Furthermore, LATAM boasts favorable regulatory frameworks that prioritize patient safety while supporting expedited trial approvals. This regulatory environment, coupled with lower operational costs compared to other regions, makes LATAM an attractive destination for sponsors seeking to conduct clinical research.
  • With Cohortias as your partner, you can tap into these benefits while ensuring high-quality data and efficient study execution. Our team of experts is well-versed in the regulatory requirements of LATAM countries and can navigate the intricacies of the local landscape to facilitate smooth trial conduct.
  • With over 20 years of experience in the industry, Cohortias has established itself as a trusted partner for sponsors seeking to conduct clinical trials in LATAM. Our extensive track record of success spans a wide range of therapeutic areas and study types, demonstrating our ability to deliver results across diverse projects.
  • Throughout our two decades in the industry, we have built strong relationships with sponsors, research sites, and regulatory authorities, enabling us to navigate the complexities of the drug development process with confidence. Our commitment to excellence and dedication to our clients’ success are the cornerstones of our approach.
  • Whether you’re conducting a phase I clinical trial or a large-scale phase III study, you can rely on Cohortias to provide the expertise, resources, and support needed to achieve your objectives. We are proud of our heritage and look forward to continuing our legacy of excellence in clinical research.